Clinical trials
Recruiting Phase 4 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Fujian Cancer Hospital | 1 |
| GFPC Investigation | 1 |
| Idris Bahce | 1 |
| Maastricht University Medical Center | 1 |
| Novartis Pharmaceuticals | 1 |
| OHSU Knight Cancer Institute | 1 |
| Rigel Pharmaceuticals | 1 |
| Samsung Medical Center | 1 |
| Shanghai Pulmonary Hospital, Shanghai, China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 12 |
| Lung Neoplasms | 6 |
| Melanoma | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Bronchial Neoplasms | 1 |
| Carcinoma, Bronchogenic | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Glioma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.